Utilization of drug treatment programs by methamphetamine users: The role of social stigma

American Journal on Addictions

Volumn 14, Issue 4, 2005, Pages 367-380

  Semple, Shirley J ^a   Grant, Igor ^a,b   Patterson, Thomas L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; COPING BEHAVIOR; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG USE; FEMALE; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; REGRESSION ANALYSIS; SOCIAL ASPECT;

ADAPTATION, PSYCHOLOGICAL; ADULT; AMPHETAMINE-RELATED DISORDERS; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; MALE; MENTAL HEALTH SERVICES; METHAMPHETAMINE; PREJUDICE; PUBLIC OPINION; REGRESSION ANALYSIS; SOCIAL CONDITIONS;

EID: 24944469871     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490591006924     Document Type: Article

References (45)

1. Link BG, Struening EL, Rahav M, et al. On stigma and its consequences: evidence from a longitudinal study of men with dual diagnoses of mental illness and substance abuse. J Health Soc Behav. 1997;38:177-190.
2. Molitor F, Truax S, Ruiz J, et al. Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med. 1998;168:93-97.
3. Morgan P. Researching Hidden Communities: A Quantitative Comparative Study of Methamphetamine Use in Three Sites. Epidemiologic Trends in Drug Abuse. Bethesda, MD, U.S. Department of Health and Human Services, National Institute of Drug Abuse; 1994.
4. National Institute of Justice. Meth Matters: Report on Methamphetamine Users in Five Western Cities. Washington, DC: US Department of Justice; 1999.
5. San Diego Association of Governments. Methamphetamine. Unpublished report.
6. San Diego Association of Governments. Arrestee Drug Abuse Monitoring (ADAM): Drug Use among the San Diego County Offender Population. San Diego, CA: Criminal Justice Research Division; September 1998.
7. Semple SJ, Patterson TL, Grant I. Motivations associated with methamphetamine use among HIV+ men who have sex with men. J Subst Abuse Treat. 2002;22:149-156.
8. Bolton J. How can we reduce the stigma of mental illness? Br Med J. 2003;S57:326.
9. Ritson EB. Alcohol, drugs and stigma. Int J Clin Pract. 1999;53:549-551.
10. Jones E, Amerigo F, Hastorf A, et al. Social Stigma: The Psychology of Marked Relationships. New York: Freeman and Company; 1984.
11. Dejong W. The stigma of obesity: the consequences of naïve assumptions concerning the causes of physical deviance. J Health Soc Behav. 1980;21:75-87.
12. Herek GM. AIDS and stigma. The American Behaviorial Scientist. 1999;42:1106-1116.
13. Link BG, Francis TC, Frank J, et al. The social rejection of former mental patients: understanding why labels matter. American Journal of Sociology. 1987;92:1461-1500.
14. Stahly GB. Psychosocial aspects of the stigma of cancer: an overview. Journal of Psychosocial Oncology. 1988;6:3-27.
15. Weitz R. Uncertainty and the lives of persons with AIDS. J Health Soc Behav. 1989;30:270-281.
16. Poindexter C, Linsk NL. HIV-related stigma in a sample of HIV-affected older female African American caregivers. Soc Work. 1999;44:46-61.
17. Dean JC, Rud F. The drug addict and the stigma of addiction. Int J Addict. 1984;19:859-869.
18. Crisp A. Changing minds: every family in the land. Pychiatr Bull. 1998;22:328-329.
19. McLaughlin D, Long A. An extended literature review of health professionals' perceptions of illicit drugs and their clients who use them. Journal of Psychiatric and Mental Health Nursing. 1996;3:283-288.
20. Chesney MA, Smith AW. Critical delays in HIV testing and care: the potential role of stigma. Am Behav Sci. 1999;42;1162-1174.
21. Goffman E. Stigma: Notes on the Management of Spoiled Identity. Englewood Cliffs, NJ: Prentice Hall; 1963.
22. Link B. Mental patient status, work and income: an examination of the effects of a psychiatric label. American Sociological Review. 1982;47: 202-215.
23. Link B. Understanding labeling effects in the area of mental disorders: an assessment of the effects of expectations of rejection. Am Social Rev. 1987;52:96-112.
24. Van Der Straten A, Vernon K, Knight K, et al. Managing HIV among serodiscordant heterosexual couples: serostatus, stigma, and sex. AIDS Care. 1998;10:533-548.
25. Link B, Francis TC, Struening E, et al. A modified labeling theory approach in the area of the mental disorders: an empirical assessment. American Sociological Review. 1989;54:400-423.
26. Page S. Effects of the mental illness label in attempts to obtain accommodation. Canadian Journal of Behavioral Science. 1977;9:85-90.
27. Rosenhan D. On being sane in insane places. Science. 1973;179:250-258.
28. George JR, Fitchen JH, Goldstein AS, et al. Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. JAMA. 1997;277:254-258.
29. Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York: The Guilford Press; 1991.
30. Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice Hall; 1986.
31. Turner CF, Forsyth BH, O'Reilly J, et al. Automated self-interviewing and the survey measurement of sensitive behaviors. In: Couper MP, ed. Computer-Assisted Survey Information Collection. New York: Wiley and Sons;1998:455-473.
32. Robins LN, Wing J, Wittchen HU, et al. The composite international diagnostic interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45:1069-1077.
33. Spitzer RL, Williams JB, Gibbon M, et al. The structured clinical interview for DSM-III-R (SCID), I: history, rationale, and description. Arch Gen Psychiatry. 1992;49:624-629.
34. Bucholz KK, Cadoret R, Cloninger RD, et al. A new semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol. 1994;55:149-158.
35. Bucholz KK, Hesselbrock VM, Shayka JJ, et al. Reliability of individual diagnostic criterion items for psychoactive substance dependence and the impact on diagnosis. J Stud Alcohol. 1995;56: 500-505.
36. Tabachnick BJ, Fidell LS. Using Multivariate Statistics. Third edition. New York: HarperCollins College Publishers; 1996.
37. Schade CP, Jones ER, Wittlin, BJ. A ten-year review of the validity and clinical utility of depression screening. Psychiatr Serv. 1998;49: 55-61.
38. Beck A. Depression: Clinical, Experimental, and Theoretical Aspects. New York: Harper & Row; 1967.
39. Murphy S, Irwin J. Living with the dirty secret: problems of disclosure for methadone maintenance clients. J Psychoactive Drugs. 1992;24: 257-264.
40. Bienev L. Perceptions by emergency room staff: substance abusers versus non-substance abusers. J Health Soc Behav. 1983;24:264-275.
41. George M, Martin E. GP's attitudes toward drug users. Br J Gen Prac. 1992;42(360):302.
42. Haleja R. The stigma facing drug abusers impedes treatment. Canadian Medical Association Journal. 1998;158:1265-1266.
43. Adair EBG, Craddock G, Miller HG, et al. Assessing consistency of responses to questions on cocaine use. Addiction. 1995;90:1497-1502.
44. Needle R, Weatherby N, Chitwood D, et al. Reliability of self-reported HIV risk behaviors of drug users. Psychol Addict Behav. 1995;9:43-51.
45. DesJarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behavior for HIV among injecting drug users: a quasi-randomized trial. Lancet. 1999;353:1657-1661.